Moderna mRNA Flu Vaccine Available in Billings

Adults aged 50 and older can now access the newly approved mFLUZIA shot at select local pharmacies.

Updated on Oct. 28, 2026 in Asthma

Moderna mRNA Flu Vaccine Available in Billings

Live Poll

Would you wait for a specific flu vaccine technology instead of getting any available shot now?

Moderna has released its mRNA-based influenza vaccine, mFLUZIA, for individuals aged 50 and older. The vaccine, which received FDA approval in September 2026, is currently rolling out to pharmacy locations in Billings.

Why it matters

The mFLUZIA vaccine provides an updated immunization option for older adults using the same mRNA technology platform previously utilized for COVID-19 vaccines. This approach was designed to improve upon existing flu vaccination methods.

The mFLUZIA vaccine is indicated strictly for adults ages 50 and older. The rollout is currently expanding across local sites following the FDA authorization granted in September 2026.

The players

Moderna

A biotechnology company known for developing mRNA-based medical solutions including COVID-19 vaccines.

Billings Clinic

A major multi-specialty healthcare provider serving patients across the region.

Intermountain Health

A regional healthcare system providing comprehensive medical and pharmacy services.

Riverstone Health

A public health and clinical service provider operating in the Billings area.

The details

The vaccine operates by using mRNA to act as a recipe card for DNA, stimulating an immune response similarly to previous mRNA-based medical developments. While retail pharmacies like CVS and Albertson's in Billings have begun stocking the product, other local providers including Billings Clinic, Intermountain Health, and Riverstone Health do not yet have doses available.

The FDA approved the mFLUZIA vaccine in September 2026.
Local availability reports were issued on October 28, 2026.

The Big Picture

The introduction of mFLUZIA marks the expansion of mRNA technology used for COVID-19 vaccines into the seasonal flu immunization space. This shift represents a broader industry trend of adapting mRNA platforms to improve the efficacy and production speed of routine respiratory disease prevention.

Residents aged 50 and older in Billings can now access the mFLUZIA vaccine at participating local pharmacies. Patients who typically receive their vaccinations at Billings Clinic, Intermountain Health, or Riverstone Health should contact these providers to confirm supply before visiting.

The takeaway

The arrival of mFLUZIA offers eligible older adults a new option for seasonal flu protection leveraging established mRNA research. Residents are encouraged to check with their preferred pharmacy or clinic for the most current information regarding local availability.